PharmacoEpidemiology and Drug Safety (PharmaSafe)
Medications are an essential aspect of health care. The PharmacoEpidemiology & Drug Safety Research Group (PharmaSafe) covers a wide range of research activities related to optimal use and safety of medication on an individual and societal level. We use epidemiological methods to address questions of drug safety that cannot be studies in randomized controlled trials (RCTs). Our work includes monitoring of drug utilization in pregnancy, perception towards medicines, methodology research, analysis of medication safety on patient outcomes and health economics.
The research group is multidiciplinary and has expertise in pharmacoepidemiology and drug safety, biostatistics, health economics and pharmacotherapy.
Guest lecture by Rebecca Bromley
Apr. 5, 2018 8:59 AM
Dr. Rebecca Broomly from University of Manchester will give a lecture on neurodevelopment of children born to mothers with epilepsy, June 8.
New article by Ingunn Björnsdottir
Mar. 15, 2018 11:34 AM
To what extent can researchers trust big data, coming from government institutions?
Norway-Sweden collaboration on information about medicines to pregnant women
Mar. 12, 2018 8:46 PM
New article and interview in Titan
Mar. 6, 2018 9:12 AM
Angela Lupattelli was recently interviewed by Titan concerning her new publication "Effect of Time-Dependent Selective Serotonin Reuptake Inhibitor Antidepressants During Pregnancy on Behavioral, Emotional, and Social Development in Preschool-Aged Children"
"Challenges in use of medications in pregnancy - how do we bridge the gap between research and practice" by Ksenia Zagorodnikova
Feb. 16, 2018 11:02 AM
On February 15, Ksenia Zagorodnikova gave the guest lecture "Challenges in use of medications in pregnancy – how do we bridge the gap between research and practice".